Cargando…
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
Fibroblast growth factor receptors (FGFRs) are aberrantly activated through single-nucleotide variants, gene fusions and copy number amplifications in 5–10% of all human cancers, although this frequency increases to 10–30% in urothelial carcinoma and intrahepatic cholangiocarcinoma. We begin this re...
Autores principales: | Krook, Melanie A., Reeser, Julie W., Ernst, Gabrielle, Barker, Hannah, Wilberding, Max, Li, Gary, Chen, Hui-Zi, Roychowdhury, Sameek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921129/ https://www.ncbi.nlm.nih.gov/pubmed/33268819 http://dx.doi.org/10.1038/s41416-020-01157-0 |
Ejemplares similares
-
Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS
por: Kautto, Esko A., et al.
Publicado: (2016) -
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
por: Chen, Hui-Zi, et al.
Publicado: (2019) -
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy
por: Krook, Melanie A., et al.
Publicado: (2019) -
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy
por: Chen, Hui-Zi, et al.
Publicado: (2021) -
Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2018)